PSTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $561,900.00

Poseida Therapeutics Insider Trading History Chart

Poseida Therapeutics Share Price & Price History

^$9.50

+0.30 (1.20%)

As of 01/8/2025 01:00 AM ET

Poseida Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2024	Mark J Gergen	Chairman	Sell	30,000	$9.46	$283,800.00	651,291
11/26/2024	Mark J Gergen	Chairman	Sell	30,000	$9.27	$278,100.00	651,291
8/8/2022	Eric Ostertag	Chairman	Buy	142,857	$3.50	$499,999.50	838,824
8/8/2022	Life Sciences Holdings L Malin	Major Shareholder	Buy	2,150,000	$3.50	$7,525,000.00	11,835,673
8/3/2022	Eric Ostertag	Chairman	Sell	160,696	$3.69	$592,968.24	695,967

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.87% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Poseida Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	339,715	$3.26M	0.0%	+10.2%	0.347%
3/18/2025	CIBRA Capital Ltd	94,495	$0.91M	0.6%	N/A	0.097%
2/19/2025	Toronto Dominion Bank	20,000	$0.19M	0.0%	N/A	0.020%
2/18/2025	GTS Securities LLC	13,796	$0.13M	0.0%	N/A	0.014%
2/17/2025	Squarepoint Ops LLC	13,950	$0.13M	0.0%	-87.6%	0.014%
2/17/2025	Toronto Dominion Bank	20,000	$0.19M	0.0%	N/A	0.020%
2/17/2025	ProShare Advisors LLC	19,334	$0.19M	0.0%	+49.0%	0.020%
2/17/2025	Nomura Holdings Inc.	5,115,015	$49.10M	0.1%	N/A	5.231%
2/17/2025	Nuveen Asset Management LLC	299,297	$2.87M	0.0%	-1.7%	0.306%
2/17/2025	OMERS ADMINISTRATION Corp	224,000	$2.15M	0.0%	N/A	0.229%
2/17/2025	Millennium Management LLC	136,116	$1.31M	0.0%	-94.3%	0.139%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	141,339	$1.36M	0.0%	-6.7%	0.145%
2/17/2025	Deutsche Bank AG	47,985	$0.46M	0.0%	+50.6%	0.049%
2/17/2025	Brevan Howard Capital Management LP	16,413	$0.16M	0.0%	N/A	0.017%
2/17/2025	Balyasny Asset Management L.P.	15,562	$0.15M	0.0%	N/A	0.016%
2/17/2025	Bank of America Corp DE	86,796	$0.83M	0.0%	-26.0%	0.089%
2/17/2025	BNP Paribas Financial Markets	37,763	$0.36M	0.0%	N/A	0.039%
2/17/2025	683 Capital Management LLC	350,000	$3.36M	0.2%	N/A	0.358%
2/14/2025	Boxer Capital Management LLC	2,000,000	$19.20M	1.6%	N/A	2.046%
2/14/2025	Jane Street Group LLC	35,452	$0.34M	0.0%	-65.7%	0.036%
2/14/2025	Fifth Lane Capital LP	50,100	$0.48M	1.4%	N/A	0.051%
2/14/2025	Pentwater Capital Management LP	8,625,000	$82.80M	0.9%	+44.4%	8.821%
2/14/2025	TIG Advisors LLC	685,595	$6.58M	0.5%	N/A	0.701%
2/14/2025	Northern Trust Corp	571,093	$5.48M	0.0%	+1.0%	0.584%
2/14/2025	The Manufacturers Life Insurance Company	25,455	$0.24M	0.0%	-6.7%	0.026%
2/14/2025	Susquehanna Fundamental Investments LLC	13,927	$0.13M	0.0%	N/A	0.014%
2/14/2025	Credit Industriel ET Commercial	80,000	$0.77M	0.1%	N/A	0.082%
2/14/2025	Voya Investment Management LLC	21,042	$0.20M	0.0%	-15.6%	0.022%
2/14/2025	Cigogne Management SA	120,000	$1.15M	0.7%	N/A	0.123%
2/14/2025	Price T Rowe Associates Inc. MD	27,677	$0.27M	0.0%	+24.7%	0.028%
2/14/2025	Silverarc Capital Management LLC	1,012,307	$9.72M	2.1%	-72.5%	1.035%
2/14/2025	MetLife Investment Management LLC	42,083	$0.40M	0.0%	+6.6%	0.043%
2/14/2025	Dimensional Fund Advisors LP	463,683	$4.45M	0.0%	-17.7%	0.474%
2/13/2025	Marshall Wace LLP	146,232	$1.40M	0.0%	+263.8%	0.150%
2/13/2025	Gamco Investors INC. ET AL	20,000	$0.19M	0.0%	N/A	0.020%
2/13/2025	Walleye Capital LLC	172,459	$1.66M	0.0%	N/A	0.176%
2/13/2025	XTX Topco Ltd	71,040	$0.68M	0.1%	-61.2%	0.073%
2/13/2025	Barclays PLC	104,822	$1.01M	0.0%	-13.0%	0.107%
2/13/2025	Summit Investment Advisors Inc.	7,182	$69K	0.1%	+28.0%	0.007%
2/13/2025	Quinn Opportunity Partners LLC	58,227	$0.56M	0.0%	N/A	0.060%
2/13/2025	Renaissance Technologies LLC	271,200	$2.60M	0.0%	-69.8%	0.277%
2/13/2025	ADAR1 Capital Management LLC	134,109	$1.29M	0.3%	N/A	0.137%
2/13/2025	FMR LLC	10,011,617	$96.11M	0.0%	-31.3%	10.240%
2/13/2025	Yakira Capital Management Inc.	177,404	$1.70M	0.6%	N/A	0.181%
2/13/2025	Wells Fargo & Company MN	37,955	$0.36M	0.0%	+22.1%	0.039%
2/12/2025	Rangeley Capital LLC	97,300	$0.93M	0.8%	N/A	0.100%
2/12/2025	Geode Capital Management LLC	1,629,759	$15.65M	0.0%	+0.8%	1.667%
2/12/2025	Franklin Resources Inc.	22,039	$0.21M	0.0%	N/A	0.023%
2/12/2025	Alliancebernstein L.P.	63,970	$0.61M	0.0%	+40.2%	0.065%
2/12/2025	Wellington Management Group LLP	339,715	$3.26M	0.0%	+10.2%	0.347%
2/12/2025	Arrowstreet Capital Limited Partnership	223,990	$2.15M	0.0%	-36.3%	0.229%
2/12/2025	Highbridge Capital Management LLC	400,000	$3.84M	0.1%	N/A	0.409%
2/12/2025	JPMorgan Chase & Co.	176,956	$1.70M	0.0%	+181.1%	0.181%
2/11/2025	Corebridge Financial Inc.	34,132	$0.33M	0.0%	-7.0%	0.035%
2/11/2025	Vanguard Group Inc.	3,834,519	$36.81M	0.0%	+4.7%	3.922%
2/11/2025	American Century Companies Inc.	42,073	$0.40M	0.0%	+20.0%	0.043%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	153,058	$1.47M	0.0%	-57.4%	0.157%
2/7/2025	Alpine Associates Management Inc.	2,016,700	$19.36M	1.2%	N/A	2.063%
2/6/2025	Charles Schwab Investment Management Inc.	589,007	$5.65M	0.0%	+3.9%	0.602%
2/4/2025	Bank of New York Mellon Corp	201,957	$1.94M	0.0%	+23.1%	0.207%
2/3/2025	Ieq Capital LLC	12,000	$0.12M	0.0%	N/A	0.012%
1/30/2025	Rhumbline Advisers	113,431	$1.09M	0.0%	+8.5%	0.116%
1/27/2025	Deltec Asset Management LLC	150,000	$1.44M	0.3%	N/A	0.153%
1/17/2025	SG Americas Securities LLC	30,623	$0.29M	0.0%	+25.4%	0.031%
1/17/2025	MCF Advisors LLC	42,854	$0.41M	0.0%	-82.7%	0.044%
1/15/2025	Trium Capital LLP	386,407	$3.71M	0.5%	N/A	0.395%
1/15/2025	Brooklyn Investment Group	4,149	$40K	0.0%	N/A	0.004%
12/26/2024	JPMorgan Chase & Co.	62,948	$0.18M	0.0%	+108.7%	0.064%
11/20/2024	Virtu Financial LLC	13,035	$37K	0.0%	N/A	0.013%
11/19/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.123%
11/16/2024	Geode Capital Management LLC	1,617,137	$4.63M	0.0%	-0.3%	1.659%
11/15/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.124%
11/15/2024	XTX Topco Ltd	182,888	$0.52M	0.0%	+47.1%	0.188%
11/15/2024	Jane Street Group LLC	103,427	$0.30M	0.0%	-5.2%	0.106%
11/15/2024	Wellington Management Group LLP	308,363	$0.88M	0.0%	-20.4%	0.316%
11/15/2024	State Street Corp	1,710,565	$4.89M	0.0%	+2.3%	1.755%
11/15/2024	Jacobs Levy Equity Management Inc.	811,512	$2.32M	0.0%	-12.5%	0.833%
11/14/2024	Fred Alger Management LLC	128,970	$0.37M	0.0%	N/A	0.132%
11/13/2024	Advantage Alpha Capital Partners LP	99,566	$0.29M	0.1%	N/A	0.102%
11/13/2024	FMR LLC	14,570,078	$41.67M	0.0%	+0.2%	14.950%
11/12/2024	Charles Schwab Investment Management Inc.	567,063	$1.62M	0.0%	+3.9%	0.584%
11/9/2024	Intech Investment Management LLC	16,159	$46K	0.0%	N/A	0.017%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	359,197	$1.03M	0.0%	+62.8%	0.370%
11/6/2024	Cornercap Investment Counsel Inc.	43,177	$0.12M	0.0%	-45.5%	0.044%
11/2/2024	Privium Fund Management B.V.	77,500	$0.22M	0.1%	N/A	0.080%
10/3/2024	SG Americas Securities LLC	24,417	$70K	0.0%	N/A	0.025%
8/15/2024	Mackenzie Financial Corp	17,616	$51K	0.0%	N/A	0.018%
8/15/2024	The Manufacturers Life Insurance Company	28,520	$83K	0.0%	+14.2%	0.029%
8/15/2024	AQR Capital Management LLC	51,741	$0.15M	0.0%	+376.5%	0.053%
8/14/2024	Squarepoint Ops LLC	82,637	$0.24M	0.0%	N/A	0.085%
8/14/2024	Marshall Wace LLP	10,538	$31K	0.0%	N/A	0.011%
8/12/2024	XTX Topco Ltd	124,301	$0.36M	0.0%	+37.1%	0.128%
8/12/2024	Blair William & Co. IL	1,101,325	$3.22M	0.0%	+14.1%	1.136%
8/9/2024	Renaissance Technologies LLC	854,900	$2.50M	0.0%	+53.4%	0.882%
8/9/2024	Dimensional Fund Advisors LP	599,812	$1.75M	0.0%	+1.6%	0.619%
8/8/2024	American Century Companies Inc.	90,487	$0.26M	0.0%	+5.9%	0.093%
8/6/2024	Acadian Asset Management LLC	399,839	$1.17M	0.0%	+9.4%	0.412%
8/1/2024	Rhumbline Advisers	97,012	$0.28M	0.0%	+4.2%	0.100%
7/31/2024	Rothschild Investment LLC	12,000	$35K	0.0%	N/A	0.012%
7/29/2024	Principal Financial Group Inc.	12,006	$35K	0.0%	N/A	0.012%

Data available starting January 2016

See Full Table

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company's development candidates for Heme Malignancies includes P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; P-CD19CD20-ALLO1, which is in Phase I trial for treating B cell malignancies and other autoimmune diseases; P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for treating multiple myeloma; and P-CD70-ALLO1 under preclinical development to treat hematological indications. It is also involved in the development of P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, colorectal, lung, ovarian, pancreatic, and renal cancers; P-PSMA-ALLO1, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in preclinical development for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC); and P-PSMA-101, an allogeneic CAR-T product candidate under Phase 1 clinical trial for treating mCRPC. In addition, the company engages in the development of P-FVIII-101, a clinical stage liver-directed gene therapy for the in vivo treatment of hemophilia A; P-OTC-101, a clinical stage liver-directed gene therapy for the in vivo treatment of ornithine transcarbamylase deficiency; and P-PAH-101, a clinical stage liver-directed gene therapy for the in vivo treatment of phenylketonuria. It has a research collaboration and license agreement with F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. The company was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $9.50

$9.50

50 Day Range

MA: $9.48

$9.33

$9.60

52 Week Range

Now: $9.50

$1.87

$9.67

Volume

N/A

Average Volume

873,188 shs

Market Capitalization

$928.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.63

Who are the company insiders with the largest holdings of Poseida Therapeutics?: Poseida Therapeutics' top insider shareholders include:
Mark J Gergen (Chairman)
Learn More about top insider investors at Poseida Therapeutics.